Literature DB >> 16936743

pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription.

G De Falco1, F Comes, C Simone.   

Abstract

The protein product of the retinoblastoma (RB) gene is necessary for the completion of the muscle differentiation program and for myogenic basic helix-loop-helix-dependent transcription. In fact, in addition to induction and maintenance of permanent cell cycle withdrawal through negative regulation of E2F-responsive genes involved in proliferation, pRb also plays a positive role in the activation of muscle-specific genes. In pRb-/- myocytes, the expression of late myogenic markers is defective and myoblast fusion into myotubes occurs without irreversible cell cycle exit. This evidence demonstrates only a partial functional redundancy between pRb and its relatives p107 and pRb2/p130, as these pRb-/- multinucleated cells, which display p107 levels higher than normal myotubes, respond to mitogens with cell cycle re-entry and DNA synthesis. At the molecular level, pRb myogenic functions are mediated by cooperation with MyoD, Myocyte enhancer factor 2 (MEF2), High mobility group box protein-1 (HBP1) and histone deacetylase1, affecting chromatin configuration and tissue-specific transcription, and by post-translational modification in response to intracellular signaling cascades.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936743     DOI: 10.1038/sj.onc.1209623

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras.

Authors:  Jun Liu; Xiao-Ju Luo; An-Wen Xiong; Zeng-di Zhang; Shen Yue; Ming-Sheng Zhu; Steven Y Cheng
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Checking before changing: cell cycle checkpoints inhibit muscle differentiation.

Authors:  Jean Y J Wang
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682.

Authors:  Yongxin Chen; Jonathan Gelfond; Linda M McManus; Paula K Shireman
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

4.  Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.

Authors:  Erica M Walsh; MengMeng Niu; Johann Bergholz; Zhi-Xiong Jim Xiao
Journal:  Biochem Biophys Res Commun       Date:  2015-04-12       Impact factor: 3.575

Review 5.  Defining the transcriptional signature of skeletal muscle stem cells.

Authors:  Z Yablonka-Reuveni; K Day; A Vine; G Shefer
Journal:  J Anim Sci       Date:  2007-09-18       Impact factor: 3.159

Review 6.  Reflections on lineage potential of skeletal muscle satellite cells: do they sometimes go MAD?

Authors:  Gabi Shefer; Zipora Yablonka-Reuveni
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

7.  E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation.

Authors:  Patrik Asp; Diego Acosta-Alvear; Mary Tsikitis; Chris van Oevelen; Brian David Dynlacht
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

8.  Retinoblastoma protein plays multiple essential roles in the terminal differentiation of Sertoli cells.

Authors:  Roopa L Nalam; Claudia Andreu-Vieyra; Robert E Braun; Haruhiko Akiyama; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2009-10-09

9.  Retinoblastoma protein modulates the inverse relationship between cellular proliferation and elastogenesis.

Authors:  Sanjana Sen; Severa Bunda; Junyan Shi; Andrew Wang; Thomas F Mitts; Aleksander Hinek
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

10.  Inhibition of mammalian muscle differentiation by regeneration blastema extract of Sternopygus macrurus.

Authors:  Hyun-Jung Kim; Eric Archer; Norma Escobedo; Stephen J Tapscott; Graciela A Unguez
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.